Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ThermoGenesis Holdings, Inc. (THMO : OTC)

• Company Description    ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California. Number of Employees: 25

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 114 shares Shares Outstanding: 7.95 (millions) Market Capitalization: $0.00 (millions) Beta: 1.04 52 Week High: $0.35 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -66.67% -68.97% 12 Week -66.67% -63.99% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2711 CITRUS ROAD - RANCHO CORDOVA,CA 95742 USA ph: 916-858-5100 fax: 916-858-5199 ir@thermogenesis.com http://www.thermogenesis.com

• General Corporate Information    Officers Chris Xu - Chief Executive Officer and Chairman Jeffery Cauble - Chief Financial Officer Russell Medford - Director Joseph Thomis - Director Biao Xi - Director Peer Information ThermoGenesis Holdings, Inc. (CORR.) ThermoGenesis Holdings, Inc. (RSPI) ThermoGenesis Holdings, Inc. (CGXP) ThermoGenesis Holdings, Inc. (BGEN) ThermoGenesis Holdings, Inc. (GTBP) ThermoGenesis Holdings, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 88362L209 SIC: 3821 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/24 Next Expected EPS Date: 05/16/25 Share - Related Items Shares Outstanding: 7.95 Most Recent Split Date: 12.00 (0.02:1) Beta: 1.04 Market Capitalization: $0.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/16/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.00 EPS Growth vs. Year Ago Period: 88.14% vs. Previous Quarter: 80.26% Sales Growth vs. Year Ago Period: 6.42% vs. Previous Quarter: 13.76% ROE 03/31/25 - - 12/31/24 - - 09/30/24 - - ROA 03/31/25 - - 12/31/24 - - 09/30/24 - - Current Ratio 03/31/25 - - 12/31/24 - - 09/30/24 - - Quick Ratio 03/31/25 - - 12/31/24 - - 09/30/24 - - Operating Margin 03/31/25 - - 12/31/24 - - 09/30/24 - - Net Margin 03/31/25 - - 12/31/24 - - 09/30/24 - - Pre-Tax Margin 03/31/25 - - 12/31/24 - - 09/30/24 - - Book Value 03/31/25 - - 12/31/24 - - 09/30/24 - - Inventory Turnover 03/31/25 - - 12/31/24 - - 09/30/24 - - Debt-to-Equity 03/31/25 - - 12/31/24 - - 09/30/24 - - Debt-to-Capital 03/31/25 - - 12/31/24 - - 09/30/24 - -

Powered by Zacks Investment Research ©